Rood技术结合家庭肺康复训练对老年特发性肺纤维化患者呼吸和运动功能的影响

The Impact of Rood Therapy Combined with Home Pulmonary Rehabilitation on Respiratory Function and Activity Capacity in Elderly Patients with Idiopathic Pulmonary Fibrosis

摘要: 目的：探讨Rood疗法联合家庭肺康复对老年特发性肺纤维化(IPF)患者呼吸功能和活动能力的影响。方法：选取21例IPF患者，按照干预方法分为对照组和观察组，所有患者接受抗纤维化药物治疗和家庭肺康复训练，观察组额外接受Rood刺激疗法。评估两组患者在治疗前，治疗第12周和第24周的FEV1% pred、6MWT距离和SGRQ评分。结果：干预后，两组患者组内前后测FEV1% pred、6MWT和SGRQ评分均较治疗前有所改善。组间测试干预12周后，观察组的FEV1% pred与对照组相比有显著差异(P = 0.020)，24周后差异更为显著(P = 0.004)。6MWT和SGRQ评分在组间后测中无明显差异。结论：Rood疗法联合家庭肺康复可有效提升IPF患者的肺通气能力，对提高有氧活动能力和生活质量具有积极作用，有助于延缓病情进展。

Abstract: Objective: To explore the effects of Rood therapy combined with home pulmonary rehabilitation on respiratory function and activity capacity in elderly patients with idiopathic pulmonary fibrosis (IPF). Methods: Twenty-one IPF patients were retrospectively enrolled and stratified into control and observation groups based on therapeutic interventions. All patients received antifibrotic agents and home-based pulmonary rehabilitation therapy; the observation group additionally underwent Rood stimulation therapy. The forced expiratory volume in one second percentage predicted (FEV1% pred), 6-minute walk test (6MWT) distance, and St. George’s Respiratory Questionnaire (SGRQ) scores were assessed for both groups before treatment and at the 12 and 24 weeks post-treatment. Results: Post-intervention, both groups showed improvements in FEV1% pred, 6MWT, and SGRQ scores compared to pre-treatment. Between-group testing at 12 weeks post-intervention revealed a significant difference in FEV1% pred between the observation and control groups (P = 0.020), with an even more pronounced difference at 24 weeks (P = 0.004). No significant differences were observed in 6MWT and SGRQ scores between groups post-treatment. Conclusion: Rood therapy combined with home pulmonary rehabilitation can effectively enhance the pulmonary ventilation capacity of IPF patients, positively impact aerobic activity capacity and quality of life, and contribute to the delay of disease progression.